PRKCD and steatosis: Furthermore, in comparison of SF group, L02 hepatocyte transfected with PKC-δ siRNA and pretreated of HQT-medicated serum demonstrating a better efficacy in FFA-induced L02 hepatocyte steatosis (p < 0.05, Fig. 5b, c, d, and e).